Supplier
MURRY S A
R/214843360014
Total received
- Contracts
- 14.217
- Agencies that bought from them
- 54
- Average contract
- $ 329.987
- Years with activity
- 18
- First contract
- 05 mar. 2004
- Last contract
- 24 dic. 2025
MURRY S A received $ 4,69 mil M from the Uruguayan state across 14.217 awards between 2004 and 2025. It sold to 54 agencies. Its largest buyer is Dirección General de la Salud, with 84% of recorded spending.
What it bid for, and against whom
Open data publishes only the winner, so losing bids appear nowhere. This comes from the bidders each purchase record publishes. It covers the 298 calls of this company we have checked so far, not all of them: the scan advances gradually.
Who it meets most often
- MEGALABS URUGUAY S A201 times
- LABORATORIO LIBRA SOCIEDAD ANONIMA185 times
- LABORATORIO GADOR S A159 times
- LABORATORIOS CELSIUS S A152 times
- GRAMON BAGO DE URUGUAY S A137 times
- FARMACO URUGUAYO S.A.136 times
- EUROFARMA URUGUAY SOCIEDAD ANONIMA129 times
- LABORATORIO ION S.A.125 times
State Suppliers Registry (RUPE)
ACTIVO- Legal name
- MURRY S A
- Fiscal domicile
- Montevideo DE HERRERA AVDA. DR. LUIS ALBE 1248 Apto. 1906 View on Google Maps
Source: ARCE — Registro Único de Proveedores del Estado (RUPE), open data. Cross-referenced to the supplier by RUT.
Revenue by year
Who buys from them
Agencies ranked by amount awarded to this supplier.
- Dirección General de la Salud$ 4,23 mil M
- Banco de Previsión Social$ 402 M
- Dirección Nacional de Sanidad de las Fuerzas Armadas$ 147 M
- Centro Hospitalario Pereira Rossell$ 51,8 M
- Dirección Nacional de Asuntos Sociales$ 44,5 M
Client concentration
84%
Dirección General de la Salud
How much of their revenue comes from their largest buyer.
Contracts
View all| Subject | Agency | Date | Amount |
|---|---|---|---|
| GONADOTROFINA RECOMBINANTE · ACITRETINA (COMPRIMIDOS)… | Centro Hospitalario Pereira Rossell | 24 dic. 2025 | $ 1,5 M |
| OMALIZUMAB ( INYECTABLE) | Dirección General de la Salud | 19 dic. 2025 | $ 64.000 |
| OMALIZUMAB ( INYECTABLE) | Dirección General de la Salud | 18 dic. 2025 | $ 64.000 |
| OMALIZUMAB ( INYECTABLE) | Dirección General de la Salud | 18 dic. 2025 | $ 160.000 |
| OMALIZUMAB ( INYECTABLE) | Dirección General de la Salud | 18 dic. 2025 | $ 160.000 |
| EXTRACTO DE CANNABIS SATIVA (SOLUCION ORAL) | Banco de Previsión Social | 16 dic. 2025 | $ 434.000 |
| CALCITRIOL (COMPRIMIDOS) · MELATONINA (COMPRIMIDOS)… | Hospital de San Carlos | 15 dic. 2025 | $ 152.780 |
| TIGECICLINA (INYECTABLE) | Hospital Maciel | 12 dic. 2025 | $ 114.930 |
10.001 suppliers